• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism.

作者信息

Linkins Lori-Ann

机构信息

Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Juravinski Hospital, Room A3-74, Hamilton, Ontario, Canada.

出版信息

BMJ Evid Based Med. 2018 Dec;23(6):230. doi: 10.1136/bmjebm-2018-111007. Epub 2018 Jun 29.

DOI:10.1136/bmjebm-2018-111007
PMID:29959155
Abstract
摘要

相似文献

1
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism.依度沙班在治疗癌症相关静脉血栓栓塞方面不劣于低分子量肝素。
BMJ Evid Based Med. 2018 Dec;23(6):230. doi: 10.1136/bmjebm-2018-111007. Epub 2018 Jun 29.
2
Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin.依度沙班用于治疗癌症相关静脉血栓栓塞，作为低分子肝素的替代药物。
Intern Emerg Med. 2018 Oct;13(7):1089-1091. doi: 10.1007/s11739-018-1886-y. Epub 2018 Jun 12.
3
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.依度沙班治疗癌症相关静脉血栓栓塞症。
N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.
4
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.依度沙班用于癌症患者静脉血栓栓塞症：来自北斋-VTE随机、双盲、双模拟试验的非劣效性亚组分析结果
Lancet Haematol. 2016 Aug;3(8):e379-87. doi: 10.1016/S2352-3026(16)30057-6. Epub 2016 Jul 1.
5
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.依度沙班用于静脉血栓栓塞症的长期治疗：Hokusai-venous thromboembolism 研究的原理和设计--临床试验的方法学意义。
J Thromb Haemost. 2013 Jul;11(7):1287-94. doi: 10.1111/jth.12230.
6
[Treatment of cancer-associated venous thromboembolism].[癌症相关静脉血栓栓塞的治疗]
G Ital Cardiol (Rome). 2018 Sep;19(9 Suppl 1):7S-12S. doi: 10.1714/2989.29922.
7
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.肺栓塞合并右心室功能不全患者的复发性静脉血栓栓塞：来自北陆-VTE研究的事后分析
Lancet Haematol. 2016 Sep;3(9):e437-45. doi: 10.1016/S2352-3026(16)30080-1.
8
Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism.依多沙班在伴有静脉血栓栓塞的表皮生长因子受体突变型非小细胞肺癌患者中的药代动力学。
Respir Investig. 2021 May;59(3):327-334. doi: 10.1016/j.resinv.2020.11.007. Epub 2020 Dec 30.
9
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.依度沙班用于静脉血栓栓塞症患者的延长抗凝治疗：来自北斋-VTE研究的事后分析
Lancet Haematol. 2016 May;3(5):e228-36. doi: 10.1016/S2352-3026(16)00023-5. Epub 2016 Mar 22.
10
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data.依度沙班治疗妇科癌症相关静脉血栓栓塞症的疗效：日本真实世界数据分析。
J Gynecol Oncol. 2022 Sep;33(5):e62. doi: 10.3802/jgo.2022.33.e62. Epub 2022 Jun 7.